LAS VEGAS — In this Healio Video Perspective from Eyecelerator@ASCRS, Edward J. Holland, MD, discusses Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%, Kala Pharmaceuticals) and its utility for patients with dry eye disease.
Uncategorized
VIDEO: Holland discusses Eysuvis for dry eye